Suchergebnisse - "Koppel, Fidi"

PubPharm (18)

1

External Validity of a Randomized Controlled Trial on Duration of Antibiotics for the Treatment of Gram-Negative Bacteremia

enthalten in: Gerontology | 2023

von Turjeman, A. | Koppel, F. | Franceschini, E. | +26

2

Duration of antibiotic treatment for Gram-negative bacteremia - Systematic review and individual participant data (IPD) meta-analysis

enthalten in: EClinicalMedicine | 2023

von Turjeman, A. | von Dach, E. | Molina, J. | +11

3

A Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection

enthalten in: Open forum infectious diseases | 2022

von Howard-Anderson, J. | Dai, W. | Yahav, D. | +13

4

In vivo fitness of carbapenem-resistant Acinetobacter baumannii strains in murine infection is associated with treatment failure in human infections

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022

von Nutman, A. | Temkin, E. | Lellouche, J. | +65

5

Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project)

enthalten in: Transplant infectious disease : an official journal of the Transplantation Society | 2021

von Pierrotti, L. | Pérez-Nadales, E. | Fernández-Ruiz, M. | +94

6

Excluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria : relevance to external validity

enthalten in: BMC infectious diseases | 2021

von Daitch, V. | Paul, M. | Daikos, G. | +27

7

Excluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria: relevance to external validity

enthalten in: BMC infectious diseases | 2021

von Daitch, V. | Paul, M. | Daikos, G. | +27

8

Piperacillin-tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae : a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen)

enthalten in: BMJ open | 2021

von Bitterman, R. | Koppel, F. | Mussini, C. | +12

9

Risk factors for functional decline among survivors of Gram-negative bloodstream infection : A prospective cohort study

enthalten in: PloS one | 2021

von Turjeman, A. | Koppel, F. | Franceschini, E. | +20

10

Colistin Resistance Development Following Colistin-Meropenem Combination Therapy Versus Colistin Monotherapy in Patients With Infections Caused by Carbapenem-Resistant Organisms

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2020

von Dickstein, Y. | Lellouche, J. | Schwartz, D. | +71